Intracoronary levosimendan for refractory coronary no-reflow during percutaneous coronary intervention: a case report

Abstract Background Coronary no-reflow during percutaneous coronary intervention (PCI) is associated with adverse clinical outcomes and remains difficult to treat when standard therapies fail. Although several pharmacological and mechanical treatment strategies have been proposed, management of refractory no-reflow remains largely empirical. Case summary In the first case, a 75-year-old man undergoing PCI of the right coronary artery for non-ST-elevation myocardial infarction developed persistent no-reflow despite thrombus aspiration, intracoronary adenosine, tirofiban, and intracoronary alteplase. In the second case, a 78-year-old man undergoing primary PCI for anterior ST-segment elevation myocardial infarction developed severe no-reflow despite balloon dilatation, thrombus aspiration, and repeated intracoronary adenosine administration. In both cases, intracoronary levosimendan was followed by rapid angiographic improvement in coronary flow from TIMI 0 to TIMI II. Discussion To our knowledge, intracoronary levosimendan for refractory coronary no-reflow during PCI has not previously been described in the clinical setting. Although causality cannot be established from two observations, the temporal association between intracoronary levosimendan administration and improvement in coronary flow suggests a potential therapeutic effect. These cases suggest that intracoronary levosimendan may be considered as an off-label rescue option in selected patients with refractory no-reflow, although its efficacy and safety require further investigation.

Authors

Institutions

Publication Details

Journal
European Heart Journal - Case Reports
Published
2026-11-12
DOI
https://doi.org/10.1093/ehjcr/ytag859
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Intracoronary levosimendan for refractory coronary no-reflow during percutaneous coronary intervention: a case report

Oscar Winnberg, Susanne Rysz, ANDERS G. HEDMAN, Johan Frederiksen
European Heart Journal - Case Reports
Coronary Interventions and Diagnostics
article

Intracoronary levosimendan for refractory coronary no-reflow during percutaneous coronary intervention: a case report

Oscar Winnberg, Susanne Rysz, ANDERS G. HEDMAN, Johan Frederiksen
article en

Abstract

Abstract Background Coronary no-reflow during percutaneous coronary intervention (PCI) is associated with adverse clinical outcomes and remains difficult to treat when standard therapies fail. Although several pharmacological and mechanical treatment strategies have been proposed, management of refractory no-reflow remains largely empirical. Case summary In the first case, a 75-year-old man undergoing PCI of the right coronary artery for non-ST-elevation myocardial infarction developed persistent no-reflow despite thrombus aspiration, intracoronary adenosine, tirofiban, and intracoronary alteplase. In the second case, a 78-year-old man undergoing primary PCI for anterior ST-segment elevation myocardial infarction developed severe no-reflow despite balloon dilatation, thrombus aspiration, and repeated intracoronary adenosine administration. In both cases, intracoronary levosimendan was followed by rapid angiographic improvement in coronary flow from TIMI 0 to TIMI II. Discussion To our knowledge, intracoronary levosimendan for refractory coronary no-reflow during PCI has not previously been described in the clinical setting. Although causality cannot be established from two observations, the temporal association between intracoronary levosimendan administration and improvement in coronary flow suggests a potential therapeutic effect. These cases suggest that intracoronary levosimendan may be considered as an off-label rescue option in selected patients with refractory no-reflow, although its efficacy and safety require further investigation.

European Heart Journal - Case Reports
Karolinska University Hospital (SE), Karolinska Institutet (SE), Stockholm South General Hospital (SE)
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon